申请人:Pfizer Inc.
公开号:US06677378B2
公开(公告)日:2004-01-13
The present invention relates to compounds of the formula
wherein R1 through R4, X, Y, m and n are defined as in the specification. Such compounds are useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.
本发明涉及公式中R1至R4、X、Y、m和n如规范中定义的化合物。这些化合物有用作为5-羟色胺、去甲肾上腺素和多巴胺的再摄取抑制剂的活性,并且其药用盐,以及它们在治疗中枢神经系统和其他疾病中的用途。